Trade INC Research - SYNH CFD

Add to favourite

42.93

View detailed chart

To be able to trade stocks like this, create an account and apply for a stock listing.

Create Account

Summary
Historical Data

Trading сonditions

Spread

0.09

Long position overnight fee

-0.023624%

Short position overnight fee

0.001401%

Overnight fee time

21:00 (UTC)

Min traded quantity

Currency

USD

Margin

5.00%

Stock exchange

United States of America

Commission on trade

Key Stats

Prev. Close	42.93
Open	42.93
1-Year Change	-9.92%
Day's Range	42.93 - 42.94

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Sep 27, 2023	42.93	0.00	0.00%	42.93	42.94	42.93
Sep 26, 2023	42.93	0.22	0.52%	42.71	42.94	42.70
Sep 25, 2023	42.73	0.04	0.09%	42.69	42.75	42.69
Sep 22, 2023	42.68	-0.08	-0.19%	42.76	42.77	42.68
Sep 21, 2023	42.73	-0.01	-0.02%	42.74	42.74	42.71
Sep 20, 2023	42.75	-0.04	-0.09%	42.79	42.80	42.74
Sep 19, 2023	42.78	0.05	0.12%	42.73	42.78	42.73
Sep 18, 2023	42.74	0.03	0.07%	42.71	42.74	42.71
Sep 15, 2023	42.70	-0.03	-0.07%	42.73	42.78	42.70
Sep 14, 2023	42.73	0.01	0.02%	42.72	42.78	42.71
Sep 13, 2023	42.73	0.03	0.07%	42.70	42.76	42.70
Sep 12, 2023	42.70	-0.02	-0.05%	42.72	42.74	42.70
Sep 11, 2023	42.72	0.07	0.16%	42.65	42.72	42.65
Sep 8, 2023	42.66	-0.02	-0.05%	42.68	42.71	42.66
Sep 7, 2023	42.69	-0.02	-0.05%	42.71	42.73	42.69
Sep 6, 2023	42.72	0.02	0.05%	42.70	42.80	42.69
Sep 5, 2023	42.68	-0.01	-0.02%	42.69	42.70	42.56
Sep 1, 2023	42.66	0.08	0.19%	42.58	42.69	42.58
Aug 31, 2023	42.68	0.04	0.09%	42.64	42.68	42.61
Aug 30, 2023	42.64	0.08	0.19%	42.56	42.65	42.55

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

1:1
2:1
3:1
5:1
10:1
20:1

Leverage

20:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

INC Research Company profile

About Syneos Health Inc

Syneos Health, Inc. is a biopharmaceutical solutions company. It provides a range of clinical and commercial services to customers in the pharmaceutical, biotechnology, and healthcare industries. It offers both stand-alone and integrated biopharmaceutical product development solutions ranging from Early Phase (Phase I) clinical trials to the full commercialization of biopharmaceutical products. It operates through two business segments: Clinical Solutions and Commercial Solutions. Clinical Solutions segment offers global services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics that span Phase I to IV of clinical development. The segment offers individual services including product development, project management, protocol development, investigational site recruitment, and clinical monitoring. The Commercial Solutions segment provides commercialization services, including deployment solutions, communication solutions, and consulting services.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Syneos Health Inc revenues increased 18% to $5.21B. Net income increased 22% to $234.8M. Revenues reflect Clinical Solutions segment increase of 21% to $4.01B, Commercial Solutions segment increase of 9% to $1.2B, North America segment increase of 13% to $3.14B, Europe, Middle East and Africa segment increase of 26% to $1.33B, Asia-Pacific segment increase of 28% to $594.2M.

Industry:

Biotechnology & Medical Research (NEC)

1030 Sync Street
MORRISVILLE
NORTH CAROLINA 27560
US